FDA Clearance Tracker · DEN230012
Ruthless Spine RJB
Last checked: Nov 20, 2026Latest source record: Jul 14, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jul 14, 2023
De Novo granted
Time to decision
148 days
Received Feb 16, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN230012
- Device name
- Ruthless Spine RJB
- Applicant
- Ruthless, LLC Dba Ruthless Spine
- Applicant location
- Irwindale, CA
- Received
- Feb 16, 2023
- Decided
- Jul 14, 2023
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.4560
- Specialty
- Orthopedic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN230012
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Ruthless, LLC Dba Ruthless Spine
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Ruthless Spine RJB510(k)
K252615 · Decided Sep 17, 2025 · 29 days after receipt
Device type: Intraoperative Surgical Angle Measurement Tool (QWL) · Orthopedic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.